These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 31749144

  • 1. Diabetes, metformin and cancer risk in myotonic dystrophy type I.
    Alsaggaf R, Pfeiffer RM, Wang Y, St George DMM, Zhan M, Wagner KR, Amr S, Greene MH, Gadalla SM.
    Int J Cancer; 2020 Aug 01; 147(3):785-792. PubMed ID: 31749144
    [Abstract] [Full Text] [Related]

  • 2. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.
    Wang Y, Pfeiffer RM, Alsaggaf R, Meeraus W, Gage JC, Anderson LA, Bremer RC, Nikolenko N, Lochmuller H, Greene MH, Gadalla SM.
    Int J Cancer; 2018 Mar 15; 142(6):1174-1181. PubMed ID: 29114849
    [Abstract] [Full Text] [Related]

  • 3. Benign tumors in myotonic dystrophy type I target disease-related cancer sites.
    Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Anderson LA, Liu Z, Koshiol J, Bauer AJ, Wagner KR, Greene MH, Amr S, Gadalla SM.
    Ann Clin Transl Neurol; 2019 Aug 15; 6(8):1510-1518. PubMed ID: 31402615
    [Abstract] [Full Text] [Related]

  • 4. Myotonic dystrophy type 1 in South Korea: a comprehensive analysis of cancer and comorbidity risks.
    Seo I, Park JM.
    Neurol Sci; 2024 Sep 15; 45(9):4573-4581. PubMed ID: 38613590
    [Abstract] [Full Text] [Related]

  • 5. Cancer Risk in Patients With Muscular Dystrophy and Myotonic Dystrophy: A Register-Based Cohort Study.
    Maya-González C, Tettamanti G, Taylan F, Skarin Nordenvall A, Sejersen T, Nordgren A.
    Neurology; 2024 Oct 22; 103(8):e209883. PubMed ID: 39298705
    [Abstract] [Full Text] [Related]

  • 6. Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
    Best AF, Hilbert JE, Wood L, Martens WB, Nikolenko N, Marini-Bettolo C, Lochmüller H, Rosenberg PS, Moxley RT, Greene MH, Gadalla SM.
    Eur J Neurol; 2019 Jan 22; 26(1):58-65. PubMed ID: 30051542
    [Abstract] [Full Text] [Related]

  • 7. Correlates of tumor development in patients with myotonic dystrophy.
    Das M, Moxley RT, Hilbert JE, Martens WB, Letren L, Greene MH, Gadalla SM.
    J Neurol; 2012 Oct 22; 259(10):2161-6. PubMed ID: 22619053
    [Abstract] [Full Text] [Related]

  • 8. Targeting Myotonic Dystrophy Type 1 with Metformin.
    García-Puga M, Saenz-Antoñanzas A, Matheu A, López de Munain A.
    Int J Mol Sci; 2022 Mar 07; 23(5):. PubMed ID: 35270043
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of cardiovascular implantable electronic devices in children with type 1 myotonic dystrophy.
    Meziab O, Seckeler MD, Scherer K, Barber BJ.
    Muscle Nerve; 2024 Nov 07; 70(5):1077-1081. PubMed ID: 38943290
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology of myotonic dystrophy type 1 (Steinert disease) in Belgrade (Serbia).
    Mladenovic J, Pekmezovic T, Todorovic S, Rakocevic-Stojanovic V, Savic D, Romac S, Apostolski S.
    Clin Neurol Neurosurg; 2006 Dec 07; 108(8):757-60. PubMed ID: 16713671
    [Abstract] [Full Text] [Related]

  • 11. Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation.
    Fernández-Torrón R, García-Puga M, Emparanza JI, Maneiro M, Cobo AM, Poza JJ, Espinal JB, Zulaica M, Ruiz I, Martorell L, Otaegui D, Matheu A, López de Munain A.
    Neurology; 2016 Sep 20; 87(12):1250-7. PubMed ID: 27558368
    [Abstract] [Full Text] [Related]

  • 12. The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research.
    Wood L, Cordts I, Atalaia A, Marini-Bettolo C, Maddison P, Phillips M, Roberts M, Rogers M, Hammans S, Straub V, Petty R, Orrell R, Monckton DG, Nikolenko N, Jimenez-Moreno AC, Thompson R, Hilton-Jones D, Turner C, Lochmüller H.
    J Neurol; 2017 May 20; 264(5):979-988. PubMed ID: 28397002
    [Abstract] [Full Text] [Related]

  • 13. On oral health in children and adults with myotonic dystrophy.
    Engvall M.
    Swed Dent J Suppl; 2010 May 20; (203):1-51. PubMed ID: 20514921
    [Abstract] [Full Text] [Related]

  • 14. Cardiac involvement in myotonic dystrophy: a nationwide cohort study.
    Lund M, Diaz LJ, Ranthe MF, Petri H, Duno M, Juncker I, Eiberg H, Vissing J, Bundgaard H, Wohlfahrt J, Melbye M.
    Eur Heart J; 2014 Aug 21; 35(32):2158-64. PubMed ID: 24742887
    [Abstract] [Full Text] [Related]

  • 15. Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity.
    Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Wagner KR, Greene MH, Amr S, Gadalla SM.
    JNCI Cancer Spectr; 2018 Nov 21; 2(4):pky052. PubMed ID: 30556050
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and correlates of apathy in myotonic dystrophy type 1.
    Gallais B, Montreuil M, Gargiulo M, Eymard B, Gagnon C, Laberge L.
    BMC Neurol; 2015 Aug 22; 15():148. PubMed ID: 26296336
    [Abstract] [Full Text] [Related]

  • 17. High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study.
    Berends J, Tieleman AA, Horlings CGC, Smulders FHP, Voermans NC, van Engelen BGM, Raaphorst J.
    Neuromuscul Disord; 2019 Oct 22; 29(10):758-765. PubMed ID: 31540818
    [Abstract] [Full Text] [Related]

  • 18. Epidemiological surveillance of myotonic dystrophy type 1: a 25-year population-based study.
    Mathieu J, Prévost C.
    Neuromuscul Disord; 2012 Nov 22; 22(11):974-9. PubMed ID: 22858159
    [Abstract] [Full Text] [Related]

  • 19. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).
    Jean S, Richer L, Laberge L, Mathieu J.
    Orphanet J Rare Dis; 2014 Nov 26; 9():186. PubMed ID: 25424323
    [Abstract] [Full Text] [Related]

  • 20. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M, Łusakowska A, Szmidt-Salkowska E, Gaweł M, Lipowska M, Sułek A, Krysa W, Rajkiewicz M, Seroka A, Kaczmarek K, Kamińska AM.
    Neurol Neurochir Pol; 2015 Nov 26; 49(3):164-70. PubMed ID: 26048604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.